Tearsheet

Joint (JYNT)


Market Price (12/27/2025): $8.89 | Market Cap: $136.4 Mil
Sector: Health Care | Industry: Health Care Facilities

Joint (JYNT)


Market Price (12/27/2025): $8.89
Market Cap: $136.4 Mil
Sector: Health Care
Industry: Health Care Facilities

Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.


0 Cash is significant % of market cap
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -21%
Weak multi-year price returns
2Y Excs Rtn is -50%, 3Y Excs Rtn is -122%
Not profitable at operating income level
Op Inc LTMOperating Income, Last Twelve Months is -0.8 Mil, Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is -1.4%
1 Strong revenue growth
Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is 2150%
  Expensive valuation multiples
P/CFOPrice/(Cash Flow from Operations). CFO is cash before capital expenditures. is 44x, P/EPrice/Earnings or Price/(Net Income) is 70x
2 Valuation becoming less expensive
P/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is -25%
  Yield minus risk free rate is negative
ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -2.7%
3 Low stock price volatility
Vol 12M is 42%
  Key risks
JYNT key risks include [1] a history of financial restatements and material weaknesses in internal controls and [2] decelerating growth fueled by marketing inefficiency and high SG&A expenses.
4 Megatrend and thematic drivers
Megatrends include Aging Population & Chronic Disease, and Health & Wellness Trends. Themes include Geriatric Care, Preventative Healthcare, Show more.
  
0 Cash is significant % of market cap
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -21%
1 Strong revenue growth
Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is 2150%
2 Valuation becoming less expensive
P/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is -25%
3 Low stock price volatility
Vol 12M is 42%
4 Megatrend and thematic drivers
Megatrends include Aging Population & Chronic Disease, and Health & Wellness Trends. Themes include Geriatric Care, Preventative Healthcare, Show more.
5 Weak multi-year price returns
2Y Excs Rtn is -50%, 3Y Excs Rtn is -122%
6 Not profitable at operating income level
Op Inc LTMOperating Income, Last Twelve Months is -0.8 Mil, Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is -1.4%
7 Expensive valuation multiples
P/CFOPrice/(Cash Flow from Operations). CFO is cash before capital expenditures. is 44x, P/EPrice/Earnings or Price/(Net Income) is 70x
8 Yield minus risk free rate is negative
ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -2.7%
9 Key risks
JYNT key risks include [1] a history of financial restatements and material weaknesses in internal controls and [2] decelerating growth fueled by marketing inefficiency and high SG&A expenses.

Valuation, Metrics & Events

JYNT Stock


Why The Stock Moved


Qualitative Assessment

AI Analysis | Feedback

The approximate -18.4% stock movement for Joint (JYNT) can be attributed to several key points derived from the company's most recent financial disclosures and market analysis, primarily surrounding its Q3 2024 earnings report and subsequent developments up to Q3 2025.

<br><br>

<b>1. Widened Net Loss:</b> The Joint Corp. reported a significant net loss of $3.2 million for the third quarter of 2024, a substantial increase from the $716,000 net loss recorded in the same period of the prior year. This widening loss likely contributed to negative investor sentiment.

<br><br>

<b>2. Decline in Adjusted EBITDA:</b> The company experienced a decrease in its Adjusted EBITDA, falling to $2.4 million in Q3 2024 from $2.9 million in Q3 2023, signaling a weakening in operational profitability.

<br><br>

<b>3. Lowered Full-Year Guidance:</b> The Joint Corp. adjusted its full-year 2024 guidance downwards for system-wide sales and comparable sales growth, reflecting a more cautious outlook on its performance due to persistent consumer headwinds.

<br><br>

<b>4. Decreased System-Wide Comparable Sales for Mature Clinics:</b> System-wide comparable sales for mature clinics, those open for 48 months or more, saw a 2% decrease in Q3 2024. This indicated challenges in maintaining growth in its more established locations.

<br><br>

<b>5. Impact of Refranchising Efforts:</b> The reported net loss in Q3 2024 included $3.8 million in charges related to clinic disposition or impairment. These charges highlight the financial costs and challenges associated with the company's strategic refranchising efforts.

Show more

Stock Movement Drivers

Fundamental Drivers

The -11.2% change in JYNT stock from 9/26/2025 to 12/26/2025 was primarily driven by a -12.3% change in the company's P/S Multiple.
926202512262025Change
Stock Price ($)9.878.76-11.25%
Change Contribution ByLTMLTM
Total Revenues ($ Mil)53.7254.441.35%
P/S Multiple2.822.47-12.32%
Shares Outstanding (Mil)15.3315.34-0.12%
Cumulative Contribution-11.25%

LTM = Last Twelve Months as of date shown

Market Drivers

9/26/2025 to 12/26/2025
ReturnCorrelation
JYNT-11.2% 
Market (SPY)4.3%41.6%
Sector (XLV)15.2%22.8%

Fundamental Drivers

The -23.3% change in JYNT stock from 6/27/2025 to 12/26/2025 was primarily driven by a -24.5% change in the company's P/S Multiple.
627202512262025Change
Stock Price ($)11.428.76-23.29%
Change Contribution ByLTMLTM
Total Revenues ($ Mil)53.0654.442.61%
P/S Multiple3.272.47-24.47%
Shares Outstanding (Mil)15.1915.34-1.04%
Cumulative Contribution-23.30%

LTM = Last Twelve Months as of date shown

Market Drivers

6/27/2025 to 12/26/2025
ReturnCorrelation
JYNT-23.3% 
Market (SPY)12.6%35.4%
Sector (XLV)17.0%26.7%

Fundamental Drivers

The -13.9% change in JYNT stock from 12/26/2024 to 12/26/2025 was primarily driven by a -2150.3% change in the company's Total Revenues ($ Mil).
1226202412262025Change
Stock Price ($)10.188.76-13.95%
Change Contribution ByLTMLTM
Total Revenues ($ Mil)-2.6654.44-2150.32%
P/S Multiple-57.352.47-104.31%
Shares Outstanding (Mil)14.9615.34-2.58%
Cumulative Contribution-14.01%

LTM = Last Twelve Months as of date shown

Market Drivers

12/26/2024 to 12/26/2025
ReturnCorrelation
JYNT-13.9% 
Market (SPY)15.8%37.7%
Sector (XLV)13.3%29.9%

Fundamental Drivers

The -40.2% change in JYNT stock from 12/27/2022 to 12/26/2025 was primarily driven by a -83.9% change in the company's P/E Multiple.
1227202212262025Change
Stock Price ($)14.658.76-40.20%
Change Contribution ByLTMLTM
Total Revenues ($ Mil)94.8354.44-42.59%
Net Income Margin (%)0.52%3.55%583.58%
P/E Multiple431.4969.51-83.89%
Shares Outstanding (Mil)14.5115.34-5.73%
Cumulative Contribution-40.40%

LTM = Last Twelve Months as of date shown

Market Drivers

12/27/2023 to 12/26/2025
ReturnCorrelation
JYNT-9.7% 
Market (SPY)48.0%30.2%
Sector (XLV)18.2%24.1%

Return vs. Risk


Price Returns Compared

 202020212022202320242025Total [1]
Returns
JYNT Return63%150%-79%-31%11%-16%-45%
Peers Return16%38%-12%21%26%16%150%
S&P 500 Return16%27%-19%24%23%18%114%

Monthly Win Rates [3]
JYNT Win Rate67%58%25%33%58%58% 
Peers Win Rate52%65%42%68%57%52% 
S&P 500 Win Rate58%75%42%67%75%73% 

Max Drawdowns [4]
JYNT Max Drawdown-50%0%-80%-47%-7%-28% 
Peers Max Drawdown-34%-5%-26%-7%-9%-23% 
S&P 500 Max Drawdown-31%-1%-25%-1%-2%-15% 


[1] Cumulative total returns since the beginning of 2020
[2] Peers: HPQ, HPE, IBM, CSCO, AAPL. See JYNT Returns vs. Peers.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 12/26/2025 (YTD)

How Low Can It Go

Unique KeyEventJYNTS&P 500
2022 Inflation Shock2022 Inflation Shock  
2022 Inflation Shock% Loss% Loss-93.1%-25.4%
2022 Inflation Shock% Gain to Breakeven% Gain to Breakeven1355.9%34.1%
2022 Inflation ShockTime to BreakevenTime to BreakevenNot Fully Recovered days464 days
2020 Covid Pandemic2020 Covid Pandemic  
2020 Covid Pandemic% Loss% Loss-52.9%-33.9%
2020 Covid Pandemic% Gain to Breakeven% Gain to Breakeven112.5%51.3%
2020 Covid PandemicTime to BreakevenTime to Breakeven149 days148 days
2018 Correction2018 Correction  
2018 Correction% Loss% Loss-31.5%-19.8%
2018 Correction% Gain to Breakeven% Gain to Breakeven45.9%24.7%
2018 CorrectionTime to BreakevenTime to Breakeven162 days120 days

Compare to HPQ, HPE, IBM, CSCO, AAPL

In The Past

Joint's stock fell -93.1% during the 2022 Inflation Shock from a high on 9/3/2021. A -93.1% loss requires a 1355.9% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth over time.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About Joint (JYNT)

The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics. The company operates in two segments, Corporate Clinics and Franchise Operations. It operates through direct ownership, management arrangements, franchising, and regional developers. As of March 1, 2022, the company operated approximately 700 locations in the United States. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.

AI Analysis | Feedback

Here are two brief analogies to describe Joint Corp. (JYNT):

  • Planet Fitness for chiropractic care.
  • MinuteClinic for chiropractic adjustments.

AI Analysis | Feedback

  • Chiropractic Adjustments: Provides spinal adjustments and other chiropractic manipulations focused on improving musculoskeletal health and relieving pain.
  • Wellness Plans: Offers membership-based plans for regular, affordable chiropractic care designed for ongoing wellness and preventative health maintenance.

AI Analysis | Feedback

The company, Joint (symbol: JYNT), is officially known as The Joint Corp. It operates a chain of chiropractic clinics across the United States.

The Joint Corp. primarily serves individuals, operating on a Business-to-Consumer (B2C) model. Its services are provided directly to patients seeking chiropractic care. Below are up to three categories of customers it serves:

  • Individuals seeking convenient and affordable chiropractic care: These customers are looking for a hassle-free experience for routine adjustments, pain relief, and general wellness. They value The Joint's walk-in model, transparent pricing (often membership-based), and focus on consumer convenience, often avoiding the complexities of insurance claims.

  • Wellness-focused individuals prioritizing preventative health: This category includes customers who incorporate chiropractic adjustments into their regular wellness routine. They use The Joint's services as part of a proactive approach to maintaining spinal health, improving posture, and overall physical well-being, rather than solely for acute pain management.

  • First-time or casual users of chiropractic services: The Joint's accessible and non-intimidating clinic environment, along with its straightforward service model, attracts individuals who may be new to chiropractic care or those who prefer a less traditional healthcare setting. It serves as an entry point for many into consistent chiropractic maintenance.

AI Analysis | Feedback

null

AI Analysis | Feedback

Sanjiv Razdan, President, Chief Executive Officer and Director

Sanjiv Razdan joined The Joint in 2024 with over 35 years of experience in franchising and hospitality. He has extensive experience growing and leading successful multi-unit companies and franchise businesses. Most recently, he served as President of Americas and India for The Coffee Bean & Tea Leaf, a global specialty coffee and tea house company operating across 1,200 cafes in 30 countries. Earlier in his career, Razdan held senior operations leadership roles with respected brands and franchisors including Yum! Brands (Pizza Hut and KFC), Dine Brands (Applebee's), and Sweetgreen. His introduction to franchising began at Pizza Hut in his home country of India, where he eventually became global operations director.

Scott J. Bowman, Chief Financial Officer

Scott J. Bowman joined The Joint as Chief Financial Officer effective June 10, 2025. He is a seasoned executive and a three-time public company CFO with over 30 years of experience across the retail, restaurant, consumer goods, and manufacturing industries. Prior to The Joint, Bowman served as CFO at Leslie's Inc., a publicly held pool supply retailer, from 2023 to 2025. He was also the CFO at True Food Kitchen, a privately held restaurant company, from 2021 to 2023, and at Dave & Buster's, a publicly held dining and entertainment company, from 2019 to 2021. From 2012 to 2019, he served as CFO at Hibbett Sports, a publicly held athletic specialty retailer that was subsequently acquired by JD Sports. Bowman's leadership experience spans both transformation and growth-stage environments.

Charles Nelles, Chief Technology Officer

Charles Nelles joined The Joint in 2022. Previously, he held the role of Vice President of Technology at American Express Global Business Travel, where he was responsible for overseeing its global technology infrastructure and service delivery processes supporting corporate travel, expense management, meetings & events, and global business consulting. Nelles has also held various executive and technology roles at Western Union, and served in leadership capacities at several healthcare organizations, including The Children's Hospital of Denver and PacifiCare Health Systems.

Beth Gross, Senior Vice President of Human Resources

Beth Gross joined The Joint in September 2024, bringing over two decades of experience in human resources. Most recently, Gross served as Vice President of Human Resources at Spear Education, a private equity-owned dental education organization based in Scottsdale, Arizona. In this role, she managed all aspects of organizational development and evolution, including talent acquisition strategy and execution, and established and led the employer branding strategy. Under her leadership, Spear Education was recognized as a "Top Companies to Work For in AZ" five times.

Craig Sherwood, Senior Vice President of Development

Craig Sherwood joined The Joint in 2025, bringing more than 25 years of executive leadership experience in global franchise development within both the fitness and QSR (Quick Service Restaurant) industries. Before joining The Joint, he was the Chief Development Officer for Lumin Fitness, an AI-powered fitness company. In that position, Sherwood was responsible for all aspects of Lumin's global franchise development, real estate, design, and construction, where he also created and launched the strategic direction for the emerging brand.

AI Analysis | Feedback

The Joint Corp (JYNT) faces several key risks to its business operations and financial stability:
  1. Financial Restatements, Internal Control Weaknesses, and Accounting Issues: The company has a history of financial restatements for the years 2020, 2021, and 2022, and has reported material weaknesses in its internal controls. These issues, stemming from accounting errors related to regional developer rights and transfer pricing, have led to concerns about diminished investor trust, potential adverse effects on stock value, significant legal and accounting expenses, and management distraction. Furthermore, Joint Corp received a delinquency notification from Nasdaq due to its failure to timely file a quarterly report, linked to ongoing evaluation of accounting treatment.

  2. Decelerating Growth, Marketing Inefficiency, and High SG&A Expenses: The Joint Corp has exhibited decelerating revenue growth and disappointing financial performance, as evidenced by its Q3 2024 results and lowered guidance across key metrics. The company struggles with marketing inefficiency, failing to effectively leverage its marketing expenditures, and experiences high selling, general, and administrative (SG&A) expenses. This indicates potential structural problems in customer acquisition and an inability to achieve economies of scale despite its expanding number of clinic locations.

  3. Labor Shortages and Increased Operating Expenses (Inflation): The company faces challenges in identifying and recruiting a sufficient number of qualified chiropractors and other personnel, exacerbated by nationwide labor shortages. This, coupled with increased operating expenses due to inflationary pressures, could negatively impact the company's profitability and operational stability.

AI Analysis | Feedback

null

AI Analysis | Feedback

The Joint Corp. (JYNT) primarily operates in the chiropractic care market in the United States, offering services such as chiropractic adjustments, pain management, and preventative care through a membership-based model that often eliminates the need for insurance.

The addressable market for chiropractic services in the U.S. has several estimates:

  • In 2022, the U.S. chiropractic market size was valued at approximately USD 450.7 million, with projections to reach USD 2,871.8 million by 2030, exhibiting a compound annual growth rate (CAGR) of 26.3% from 2023 to 2030.
  • Other estimates place the U.S. chiropractic market size at USD 21.4 billion in 2024, anticipated to reach USD 21.9 billion in 2025.
  • Another report indicated the U.S. chiropractic market size was approximately USD 13.75 billion in 2024 and is predicted to grow to about USD 22.94 billion by 2034, with a CAGR of roughly 4.76% between 2025 and 2034.
  • For North America, the U.S. led the chiropractic market in 2024, generating revenue of about USD 8.3 billion.

AI Analysis | Feedback

The Joint Corporation (JYNT) is expected to drive future revenue growth over the next 2-3 years through several key strategies:
  1. Refranchising Strategy: The company is actively pursuing a refranchising strategy, selling corporate-owned clinics to franchisees. This shifts the revenue model towards increased franchise royalties and fees, which is a core strategic focus for enhancing profitability and generating revenue from its asset-light model. This initiative is expected to lead to more profitable continuing operations in 2026.
  2. New Franchise Clinic Openings: Expanding the network of franchised clinics is a direct driver of revenue growth. The Joint Corp. continues to sell new franchise licenses and open new clinics, contributing to the overall increase in clinics in operation and subsequently, higher revenue from franchise operations.
  3. Digital Marketing and Technology Initiatives: Investment in enhancing brand positioning and strengthening digital marketing efforts aims to increase patient acquisition and retention. Initiatives such as national marketing campaigns, bolstering digital marketing to boost organic search traffic, and upgrading the patient-facing mobile app are designed to improve system-wide sales.
  4. Improved Clinic Economics and Patient Count: The company is focused on strategies to improve clinic economics and increase patient count. This includes efforts to drive overall system-wide sales and comparable sales by attracting more patients and enhancing the value proposition, implicitly incorporating pricing optimization for affordability and patient value through dynamic revenue management.

AI Analysis | Feedback

Share Repurchases

  • The board of directors authorized an additional $12 million for its stock repurchase program in November 2025.
  • The company repurchased 540,000 shares for approximately $5 million between August and October 2025.
  • During the third quarter of 2025, The Joint Corp. repurchased 228,000 shares for $2.3 million.

Inbound Investments

  • The company entered an initial agreement to sell 45 corporate clinics in Southern California for an aggregate purchase price of $4.5 million, comprising $3,154,500 in cash and $1,345,500 in prorated franchise fees.

Capital Expenditures

  • Cash used in investing activities totaled $527,294 for the third quarter ended September 30, 2024.
  • For 2025, the company plans to continue reinvesting in its brand and enhancing its IT platforms.
  • Strategic investments in 2025 include digital marketing, mobile apps, and a new pricing pilot, all aimed at patient acquisition and business optimization.

Better Bets than Joint (JYNT)

Trade Ideas

Select ideas related to JYNT. For more, see Trefis Trade Ideas.

Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
CRL_11142025_Dip_Buyer_FCFYield11142025CRLCharles River Laboratories InternationalDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
21.4%21.4%-3.7%
GDRX_11142025_Dip_Buyer_High_CFO_Margins_ExInd_DE11142025GDRXGoodRxDip BuyDB | CFO/Rev | Low D/EDip Buy with High Cash Flow Margins
Buying dips for companies with significant cash flows from operations and reasonable debt / market cap
-7.4%-7.4%-11.8%
ASTH_11142025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG11142025ASTHAstrana HealthDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap
18.0%18.0%-5.5%
SGRY_11142025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG11142025SGRYSurgery PartnersDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap
3.9%3.9%-1.4%
TFX_11072025_Dip_Buyer_FCFYield11072025TFXTeleflexDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
12.2%12.2%-5.1%

Recent Active Movers

More From Trefis

Peer Comparisons for Joint

Peers to compare with:

Financials

JYNTHPQHPEIBMCSCOAAPLMedian
NameJoint HP Hewlett .Internat.Cisco Sy.Apple  
Mkt Price8.7623.2624.49305.0978.16273.4051.32
Mkt Cap0.121.932.6284.9309.24,074.4158.8
Rev LTM5455,29534,29665,40257,696408,62556,496
Op Inc LTM-13,6241,64411,54412,991130,2147,584
FCF LTM22,80062711,85412,73396,1847,327
FCF 3Y Avg62,9781,40011,75313,879100,5037,366
CFO LTM33,6972,91913,48313,744108,5658,590
CFO 3Y Avg93,6723,89613,49814,736111,5598,697

Growth & Margins

JYNTHPQHPEIBMCSCOAAPLMedian
NameJoint HP Hewlett .Internat.Cisco Sy.Apple  
Rev Chg LTM2,150.3%3.2%13.8%4.5%8.9%6.0%7.4%
Rev Chg 3Y Avg689.7%-3.9%6.5%2.6%3.7%1.8%3.2%
Rev Chg Q5.7%4.2%14.4%9.1%7.5%9.6%8.3%
QoQ Delta Rev Chg LTM1.4%1.1%3.7%2.1%1.8%2.1%2.0%
Op Mgn LTM-1.4%6.6%4.8%17.7%22.5%31.9%12.1%
Op Mgn 3Y Avg-7.4%7.2%16.4%24.2%30.8%16.4%
QoQ Delta Op Mgn LTM1.2%-0.2%-1.4%0.6%0.4%0.1%0.2%
CFO/Rev LTM5.6%6.7%8.5%20.6%23.8%26.6%14.6%
CFO/Rev 3Y Avg-6.8%12.7%21.4%26.1%28.4%21.4%
FCF/Rev LTM3.0%5.1%1.8%18.1%22.1%23.5%11.6%
FCF/Rev 3Y Avg-5.5%4.6%18.6%24.6%25.6%18.6%

Valuation

JYNTHPQHPEIBMCSCOAAPLMedian
NameJoint HP Hewlett .Internat.Cisco Sy.Apple  
Mkt Cap0.121.932.6284.9309.24,074.4158.8
P/S2.50.41.04.45.410.03.4
P/EBIT-172.76.819.925.122.531.321.2
P/E69.58.6572.736.029.941.038.5
P/CFO43.85.911.221.122.537.521.8
Total Yield1.4%14.1%2.3%5.0%5.4%2.8%3.9%
Dividend Yield0.0%2.5%2.1%2.2%2.1%0.4%2.1%
FCF Yield 3Y Avg4.4%10.6%5.5%6.4%6.0%3.1%5.7%
D/E0.00.50.70.20.10.00.2
Net D/E-0.20.30.60.20.00.00.1

Returns

JYNTHPQHPEIBMCSCOAAPLMedian
NameJoint HP Hewlett .Internat.Cisco Sy.Apple  
1M Rtn3.8%-1.8%14.4%0.6%2.7%-1.5%1.7%
3M Rtn-11.2%-11.9%2.7%7.9%17.0%7.1%4.9%
6M Rtn-23.3%-4.0%34.5%6.6%15.2%36.3%10.9%
12M Rtn-13.9%-27.3%14.2%39.2%33.7%6.0%10.1%
3Y Rtn-40.2%-3.8%67.7%139.0%79.5%113.4%73.6%
1M Excs Rtn0.8%-5.6%12.9%-2.2%-0.0%-3.7%-1.1%
3M Excs Rtn-15.6%-16.2%-1.7%3.6%12.7%2.8%0.6%
6M Excs Rtn-35.6%-16.3%22.3%-5.7%3.0%24.0%-1.3%
12M Excs Rtn-29.0%-42.9%-0.7%25.0%19.9%-8.4%-4.6%
3Y Excs Rtn-121.8%-83.5%-11.2%59.6%-1.2%28.4%-6.2%

Financials

Segment Financials

Revenue by Segment
$ Mil20242023202220212020
Franchise operations52    
Total52    


Net Income by Segment
$ Mil20242023202220212020
Franchise operations-6    
Total-6    


Price Behavior

Price Behavior
Market Price$8.76 
Market Cap ($ Bil)0.1 
First Trading Date11/11/2014 
Distance from 52W High-31.5% 
   50 Days200 Days
DMA Price$8.43$10.16
DMA Trenddowndown
Distance from DMA4.0%-13.7%
 3M1YR
Volatility34.5%42.6%
Downside Capture135.8490.97
Upside Capture51.0062.59
Correlation (SPY)41.4%37.6%
JYNT Betas & Captures as of 11/30/2025

 1M2M3M6M1Y3Y
Beta0.711.211.181.250.820.98
Up Beta0.201.411.691.900.520.68
Down Beta0.791.061.071.861.271.15
Up Capture133%58%19%25%44%64%
Bmk +ve Days13263974142427
Stock +ve Days8152152108329
Down Capture52%160%172%131%101%106%
Bmk -ve Days7162452107323
Stock -ve Days11263969133402

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
 Comparison of JYNT With Other Asset Classes (Last 1Y)
 JYNTSector ETFEquityGoldCommoditiesReal EstateBitcoin
Annualized Return-14.7%15.1%17.8%72.1%8.6%4.4%-8.3%
Annualized Volatility42.4%17.2%19.4%19.3%15.2%17.0%35.0%
Sharpe Ratio-0.260.650.722.700.340.09-0.08
Correlation With Other Assets 29.6%37.5%-7.1%7.6%34.8%11.6%

ETFs used for asset classes: Sector ETF = XLV, Equity = SPY, Gold = GLD, Commodities = DBC, Real Estate = VNQ, and Bitcoin = BTCUSD
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
 Comparison of JYNT With Other Asset Classes (Last 5Y)
 JYNTSector ETFEquityGoldCommoditiesReal EstateBitcoin
Annualized Return-19.9%8.4%14.7%18.7%11.5%4.6%30.8%
Annualized Volatility59.4%14.5%17.1%15.5%18.7%18.9%48.7%
Sharpe Ratio-0.130.400.700.970.500.160.57
Correlation With Other Assets 25.9%38.0%2.9%4.7%33.1%24.1%

ETFs used for asset classes: Sector ETF = XLV, Equity = SPY, Gold = GLD, Commodities = DBC, Real Estate = VNQ, and Bitcoin = BTCUSD
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
 Comparison of JYNT With Other Asset Classes (Last 10Y)
 JYNTSector ETFEquityGoldCommoditiesReal EstateBitcoin
Annualized Return5.5%9.9%14.8%15.3%7.0%5.3%69.2%
Annualized Volatility58.6%16.6%18.0%14.7%17.6%20.8%55.8%
Sharpe Ratio0.340.490.710.860.320.220.90
Correlation With Other Assets 26.2%35.2%-0.0%11.2%31.8%13.5%

ETFs used for asset classes: Sector ETF = XLV, Equity = SPY, Gold = GLD, Commodities = DBC, Real Estate = VNQ, and Bitcoin = BTCUSD
Smart multi-asset allocation framework can stack odds in your favor. Learn How

Short Interest

Short Interest: As Of Date12152025
Short Interest: Shares Quantity813,800
Short Interest: % Change Since 1130202517.1%
Average Daily Volume112,896
Days-to-Cover Short Interest7.21
Basic Shares Quantity15,344,844
Short % of Basic Shares5.3%

Earnings Returns History

Expand for More
 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
11/6/2025-3.9%3.5%9.3%
7/30/2025-4.0%-3.2%-7.2%
5/8/2025-5.1%-4.0%13.2%
1/16/20251.7%2.6%4.8%
11/7/2024-2.3%-5.6%-2.9%
8/8/2024-8.4%-5.7%-10.2%
3/7/202430.0%29.1%41.2%
11/9/202312.9%12.8%29.9%
...
SUMMARY STATS   
# Positive101010
# Negative101010
Median Positive5.2%10.6%15.7%
Median Negative-4.6%-5.6%-20.3%
Max Positive30.0%29.1%41.2%
Max Negative-37.9%-40.0%-41.8%

SEC Filings

Expand for More
Report DateFiling DateFiling
93020251107202510-Q 9/30/2025
6302025812202510-Q 6/30/2025
3312025509202510-Q 3/31/2025
12312024314202510-K 12/31/2024
93020241108202410-Q 9/30/2024
6302024809202410-Q 6/30/2024
3312024503202410-Q 3/31/2024
12312023308202410-K 12/31/2023
93020231113202310-Q 9/30/2023
6302023926202310-Q 6/30/2023
3312023505202310-Q 3/31/2023
12312022310202310-K 12/31/2022
93020221104202210-Q 9/30/2022
6302022805202210-Q 6/30/2022
3312022506202210-Q 3/31/2022
12312021314202210-K 12/31/2021